Skip to main content

Award-Winning Artist, UNC Physician Partner to Raise Over $154,700 for Pediatric Cancer in Malawi

June 28, 2019
  Mark Robinson visits with a therapy dog at UNC Hospitals. Grammy-nominated musician, record producer, and Chapel Hill native Porter Robinson first met pediatric oncologist Dr. Kate Westmoreland in November 2016, when Porter’s younger brother Mark came into Dr. Westmoreland’s care at UNC Hospitals. Three years later, they have raised...

Treating Burkitt Lymphoma in Children and AYA in Sub-Saharan Africa

July 19, 2018
July 2018- Although highly effective, high-intensity cytotoxic treatments for Burkitt lymphoma are available in resource-rich settings, these therapies are usually not feasible in SSA, and lower-intensity continuous infusion approaches are impractical. We review current treatment approaches in SSA and discuss options for risk stratification and individualize therapy.

Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis

April 3, 2017
March 2017 – Diagnosing pediatric Burkitt Lymphoma in sub-Saharan Africa is difficult, as many tools are currently not available. This study found that measuring Epstein-Barr virus DNA could help with setting the diagnosis, prognosis, and predicting the response.

Impact of loss to follow-up on pediatric lymphoma study outcome

December 13, 2016
November 2016 – Limited follow-up with incomplete retention is common among studies involving pediatric lymphoma patients in sub-Saharan Africa. This study examines the effects of retention and follow-up times on overall survival estimates.